The global geriatric medicine market size was valued at US$ 769.96 billion in 2021 and is expected to grow at a CAGR of 6.8% over forecast period 2022 to 2030.
The global geriatric medicine market size was valued at US$ 769.96 billion in 2021 and is expected to grow at a CAGR of 6.8% over forecast period 2022 to 2030.
The global geriatric medicine market size is projected to surpass over US$ 1,391.90 billion by 2030.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/34907
The study has considered the base year as 2020, which estimates the market size of market and the forecast period is 2022 to 2030. The report analyzes and forecasts the market size, in terms of volume (thousand units) and value (USD million), for the market. The report provides a detailed analysis of various forces acting in the market (drivers, restraints, opportunities, and challenges). The report covers key players and comprehensively analyzes their market shares and core competencies. It also tracks and analyzes competitive developments such as joint ventures, mergers & acquisitions, new product launches, expansions, and other activities carried out by key industry participants.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 769.96 billion |
| Revenue Forecast by 2030 | USD 1,391.90 billion |
| Growth rate from 2022 to 2030 | CAGR of 6.8% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Therapeutic Category, Condition, Distribution Channel, Region |
| Companies Covered | Pfizer, Inc., Merck & Co., Inc., AstraZeneca, Bristol-Myers Squibb Company, Novartis AG, Sanofi S.A., GlaxoSmithKline plc Eli Lilly and Company, Abbott Laboratories, Boehringer Ingelheim GmbH |
Overview
- Geriatric medicines are a specialty branch of medical science that provides diagnosis and treatment options for the elderly. Most geriatrics are unable to take their medication properly at a scheduled time, due to complex medical and psychological problems. The geriatric population requires special care and attention for the speedy recovery of disease or disorder.
- The global geriatric medicines market is expanding at a significant pace due to increasing government support toward old people for their health, safety, and nursing care. Developed nations already have quality geriatric care management systems in place and developing nations are making high investments in geriatric care.
- North America dominated the global geriatric medicine market in 2021 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, concentration of global market players, and high awareness about latest therapeutic advancements in the region are expected to drive the market in North America.
- Asia Pacific is likely to be a highly lucrative market for retinal disorders and it is expected to expand at a high CAGR during the forecast period
High Incidence of Chronic Disease and Increase Government Support for Elderly to Drive Market
- Rise in geriatric population coupled with increase in incidence of chronic diseases is expected to propel the demand for geriatric medicines High incidence of unintended pregnancies is likely to drive the market. According to the Centers for Disease Control and Prevention (CDC), stroke claims one fatality every 40 seconds in the U.S. and about 795,000 people become victims of stroke (85% acute ischemic) each year. About 610,000 of these are first or new strokes, and 185,000 are recurrent strokes.
- The Long Term Care Ombudsman Program provides nursing homes, residential care facilities, and assisted living facilities for elderly people in the U.S. Moreover, developing nations, such as India, China, and South Korea, are adopting policies and services for the benefit of elderly people. Therefore, the geriatric medicines market is likely to expand at a significant growth rate from 2022 to 2030.
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/34907
Restraints
Some kind of medicines can have adverse effect on the health of geriatrics. The old people are quite sensitive to medicines and need proper prescription of drugs and medications. Sometimes overdose of drugs and medications can also lead to the death of geriatric. Therefore, healthcare professionals must prescribe medicines in proper amount to the elderly population. Thus, side effects of medicines are restricting the expansion of global geriatric medicines market.
Analgesic Segment to Dominate Market
- Based on therapeutic category, the global geriatric medicine market has been divided into analgesic, antihypertensive, statins, antidiabetic, proton pump inhibitor, combination pills, progestin-only pills, anticoagulant, antipsychotic & antidepressant and others.
- The analgesic segment dominated the global geriatric medicine market in 2021 and the trend is projected to continue during the forecast period. Increasing need for pain killers for various chronic conditions, such as arthritis, is projected to boost the segment during the forecast period
Cardiovascular to be Highly Lucrative Segment
- In terms of condition, the global geriatric medicine market has been classified into cardiovascular, arthritis, diabetes, neurological, cancer, osteoporosis, respiratory and others.
- Rising geriatric population being overweight increases the risk of heart attacks and strokes, which in turn drives the segment
- The generic geriatric medicine are available at low cost drugs with similar bioavailability and bioequivalence as the branded drugs, rising preference for generic drugs among patients will drive cardiovascular segment growth during the forecast period.
North America to Dominate Global Market
- In terms of region, the global geriatric medicine market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global geriatric medicine market in 2021, followed by Europe.
- North America accounted for major share of the global geriatric medicine market in 2021, high percentage of obese population susceptible to chronic diseases is a major factor driving the geriatric medicines market in North America.
- Moreover, clinical studies and research projects are growing in scope and size, and new initiatives focused on management of geriatric health and population-based research are underway in North America
- The Geriatric medicine market in Asia Pacific is anticipated to expand at a high CAGR from 2022 to 2030. This can be attributed to rapid economic growth in developing economies such as India, China, Indonesia, Vietnam, South Korea, and the Philippines. Availability of generic medicines at lower prices is fueling market growth.
Related Reports
- mRNA Synthesis Raw Materials Market Report 2022-2030 - https://www.visionresearchreports.com/mrna-synthesis-raw-materials-market/39906
- Bioequivalence Studies Market Report 2022-2030 - https://www.visionresearchreports.com/bioequivalence-studies-market/39904
- Medical Crutches Market Report 2022-2030 - https://www.visionresearchreports.com/medical-crutches-market/39902
Leading players operating in the global geriatric medicine market are
- Pfizer, Inc.
- Merck & Co., Inc.
- AstraZeneca
- Bristol-Myers Squibb Company
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc Eli Lilly and Company
- Abbott Laboratories
- Boehringer Ingelheim GmbH
Segmentation
The global geriatric medicine market has been segmented as follows:
- Global Geriatric medicine Market, by Therapeutic Category
- Analgesic
- Antihypertensive
- Statins
- Antidiabetic
- Proton Pump Inhibitor
- Anticoagulant
- Antipsychotic and Antidepressant
- Others
- Global Geriatric medicine Market, by Condition
- Cardiovascular
- Arthritis
- Diabetes
- Neurological
- Cancer
- Osteoporosis
- Respiratory
- Others
- Global Geriatric medicine Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Geriatric medicine Market, by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Click Here to View Full Report Table of Contents
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/34907
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://qyresearchmedical.com/